In this discussion, Luke Slindee, a pharmacy consultant, unravels the tangled web of generic drug pricing and its impact on patients. He reveals how Pharmacy Benefit Managers (PBMs) profit from inflated costs, often making patients pay more even when insured. They explore innovative solutions like removing unnecessary price structures and the benefits of direct payment tools. Luke also touches on the broader implications of these pricing challenges on pharmacies and the services they provide, all while advocating for a system that prioritizes patient affordability.

Exploring pharmacy acronyms like AWP and WAC, the podcast dives into the complexities of drug pricing and rebates. It unravels the hidden world of pharmacy supply chain economics and the impact on patients and plan sponsors. The discussion delves into the challenges faced by pharmacies dealing with Pharmacy Benefit Managers and the pricing dynamics of generic drugs. Dysfunction in the pharmaceutical industry is also explored, revealing its consequences on pharmacy operations and patient access.